Antares Pharma, Inc. (NASDAQ:ATRS)

Top Analyst Upgrades and Downgrades: Allscripts, AmeriGas, CVS, IMAX, Kraft Heinz, Marathon Oil, Microsoft, Pfizer and Many More

Stocks were indicated to open higher by over 100 more points on the Dow Jones industrial average and 13 points on the S&P 500 on additional China-trade developments as tariff ...
Read Full Story »

Why AMAG Pharmaceuticals Is Soaring

AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval. Specifically, the company said that the FDA approved ...
Read Full Story »

Even More Biopharma and FDA Catalysts Coming in October

As the markets continue to hit all-time highs, biotech and pharmaceutical companies have been part of these massive gains. There is a very positive sentiment in the health care sector ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, Altice USA, Biogen, Caterpillar, Gilead, Oracle and Many More

Stocks have recently hit all-time highs again, but the stock indexes seem to have gone sideways in recent days and they were looking for direction on a slow news Friday. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Costco, Domino’s Pizza, Fortinet, Verizon, Yum Brands and More

After a huge Thursday in which the markets soared, the futures traded flat to modestly higher Friday morning. With earnings still coming in hot and heavy, many on Wall Street are ...
Read Full Story »

Analyst Offers Top US Growth Stock Calls for This Week

With summer just around the corner, one thing is for sure. Investors may start to see volume slowing and the action could get a little mixed. While “sell in May ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Antares, Michael Kors, Palo Alto, Ralph Lauren, Chipotle, Ericsson, and More

Stocks were indicated lower on Thursday, but stock sectors by and large seemed to have no clear direction ahead of the open. What keeps getting shown by the investor group ...
Read Full Story »
Food and Drug Administration logo

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

It looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is that ...
Read Full Story »

Oppenheimer Resumes Coverage of Biotechnology With Top Stocks to Buy

Even the best firms on Wall Street sometimes lose their analysts, and when that happens they are forced to suspend their coverage on stocks until they can replace the talent. ...
Read Full Story »